Last reviewed · How we verify
NCT03186391: ExercisePAD
Exercise Testing in Peripheral Artery Disease Patients
Recruiting now
Last updated 11 March 2025
What this trial tests
trial testing Data collected in Peripheral Artery Disease in 5,000 participants. Currently enrolling.
Timeline
24 February 2014
Primary endpoint
31 December 2030
31 December 2030
31 December 2030
Quick facts
| Lead sponsor | Rennes University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 24 February 2014 |
| Primary completion | 31 December 2030 |
| Estimated completion | 31 December 2030 |
| Sites | 1 location across France |
Drugs / interventions tested
- Data collected
Conditions studied
- Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Sponsor
Rennes University Hospital
Who can join
18 Months and older, any sex, with Peripheral Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to evaluate exercise testing in case of patients suspected of Peripheral Artery Disease (PAD).
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography.
Stivalet O, Paisant A, Belabbas D, Omarjee L, et al · · 2019 · cited 24× · PMID 31247050 · DOI 10.1371/journal.pone.0219082 -
Discordance of peripheral artery disease diagnosis using exercise transcutaneous oxygen pressure measurement and post-exercise ankle-brachial index.
Mahé G, Catillon F, Tollenaere Q, Jéhannin P, et al · · 2020 · cited 6× · PMID 32366896 · DOI 10.1038/s41598-020-64276-x -
Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease.
Stivalet O, Paisant A, Belabbas D, Le Faucheur A, et al · · 2021 · cited 4× · PMID 34901219 · DOI 10.3389/fcvm.2021.759666 -
Arterial Doppler Waveforms Are Independently Associated With Maximal Walking Distance in Suspected Peripheral Artery Disease Patients.
Miossec A, Tollenaere Q, Lanéelle D, Guilcher A, et al · · 2021 · cited 3× · PMID 33959640 · DOI 10.3389/fcvm.2021.608008 -
Use of the Walking Impairment Questionnaire and Walking Estimated-Limitation Calculated by History questionnaire to detect maximal walking distance equal to or lower than 250 m in patients with lower extremity arterial disease.
Tollenaere Q, Métairie A, Le Pabic E, Le Faucheur A, et al · · 2023 · cited 2× · PMID 37025694 · DOI 10.3389/fcvm.2023.968213 -
Simplification of ankle-brachial-index measurement using Doppler-waveform classification in symptomatic patients suspected of lower extremity artery disease.
Métairie A, Tollenaere Q, Lanéelle D, Le Faucheur A, et al · · 2022 · cited 1× · PMID 36158813 · DOI 10.3389/fcvm.2022.941600 -
Relationship between exercise transcutaneous oxygen pressure measurements with constant and graded treadmill tests.
Vannier C, Guézais A, Talbot M, Le Faucheur A, et al · · 2025 · PMID 41193436 · DOI 10.1177/1358863x251379810
Verify or expand the search:
- PubMed search for NCT03186391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data collected
Trials testing the same drug.
- NCT05147012 — Intraoperative Hypotension Predicted by Mean Arterial Pressure · completed
Other recruiting trials for Peripheral Artery Disease
Currently open trials in the same condition.
- NCT07374601 — The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease · recruiting
- NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
- NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting
Other Rennes University Hospital trials
Trials by the same sponsor.
- NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
- NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
- NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
- NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
- NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT03186391 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
- Last refreshed: 11 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03186391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing